One-glance verdict
Not enough data
Fair value unavailable
Not enough cash-flow history to value this one with our method.
Fundamentals snapshot
OrthoPediatrics Corp.
KIDS · NGM · Healthcare · Medical Devices
Current price
$30.87
52-week range
$14.42 - $32.62
Market cap
$806.03M
Balance sheet
Distressed
-11.96x Concerning
Net debt $66.62M. Interest coverage shows how many times profit covers the interest bill.
What stands out
1 Reward
1 Risk
1 rewards · 1 risks
- Reward Revenue grew 11.8% last year.
- Risk Return on equity was -9.8% last year — the company lost money on shareholders' equity.
What this company does
OrthoPediatrics Corp.
OrthoPediatrics Corp. makes special medical tools like implants and braces designed just for kids who have bone or spine problems. Their main income comes from selling these products to doctors and hospitals who treat these young patients. This matters because it shows how the company helps a specific group of people with their unique medical needs.
How the company got here
OrthoPediatrics Corp. was founded in 2006 with a clear mission: to address the unique orthopedic needs of children. Before its inception, many medical devices were simply smaller versions of adult implants, not always suitable for developing bodies. The company recognized this gap and focused on creating specialized solutions. This dedication to a specific patient population has been the driving force behind its growth and product development.
What it actually does
OrthoPediatrics designs, develops, and sells medical devices specifically for children facing orthopedic challenges. Think of them as creating specialized tools for doctors who treat broken bones, bone deformities, or spinal issues in kids. These aren't just generic tools; they are carefully crafted to fit a child's growing anatomy, aiming for better outcomes and recovery. Their products range from implants that help bones heal to braces that correct spinal curves.
Pediatric Trauma and Deformity Correction
This is a core part of OrthoPediatrics' business, focusing on fixing broken bones and correcting unusual bone shapes in children. They offer a variety of implants, like specialized plates and screws (PediPlates, cannulated screws) and nails that go inside the bone (PediNail, PediFlex nail), designed to fit a child's smaller and still-growing bones. These products help surgeons set fractures and reshape limbs, ensuring proper healing and development.
Scoliosis Procedures
This segment addresses spinal deformities, most commonly scoliosis, in children. Scoliosis is a condition where a child's spine curves sideways. OrthoPediatrics provides specialized systems, such as the RESPONSE Spine and ApiFix Mid-C System, which are designed to correct these curves. These systems help surgeons align the spine, preventing further progression of the curve and improving posture and function.
Sports Medicine and Other Products
Beyond trauma and scoliosis, OrthoPediatrics also offers solutions for sports-related injuries and other orthopedic needs in children. This includes products for knee ligament reconstruction, like their ACL Reconstruction System, and other specialized instruments and implants. They also provide devices like spica tables, which help position children for surgery, and growth modulation devices (GIRO Growth Modulation System) that can guide bone growth.
What management is betting on now
OrthoPediatrics is focused on expanding its product offerings and reaching more children globally. They are likely investing in research and development to create even more innovative solutions for pediatric orthopedic conditions. A key strategy involves growing their international presence, bringing their specialized devices to more markets. They also aim to deepen relationships with pediatric orthopedic surgeons, ensuring their products are the go-to choice for treating children's bone and spine issues.
Price history
How the share price has moved
—
Loading price history…
Earnings history
Last 8 quarters — what happened
Click any quarter to read the call summary and what the numbers say.
FY2024 Q4
$-4.25M
FY2025 Q1
$-8.38M
FY2025 Q2
$-13.91M
FY2025 Q3
$-3.42M
FY2025 Q4
$9.75M
FY2026 Q1
$-5.05M
FY2026 Q2
$-3.12M
FY2026 Q3
$1.59M
Revenue
$72.66M
Net income
$-5.93M
Diluted EPS
-0.25
Operating cash flow
$4.51M
Free cash flow
$1.59M
Fetching…
Sources
Revenue
$70.51M
Net income
$-7.16M
Diluted EPS
-0.30
Operating cash flow
$928.00K
Free cash flow
$-3.12M
Fetching…
Sources
Revenue
$59.36M
Net income
$-10.69M
Diluted EPS
-0.45
Operating cash flow
$-3.29M
Free cash flow
$-5.05M
Fetching…
Sources
Revenue
$61.60M
Net income
$-10.10M
Diluted EPS
-0.43
Operating cash flow
$10.35M
Free cash flow
$9.75M
Fetching…
Sources
Revenue
$61.25M
Net income
$-11.77M
Diluted EPS
-0.50
Operating cash flow
$-581.00K
Free cash flow
$-3.42M
Fetching…
Sources
Revenue
$61.08M
Net income
$-7.11M
Diluted EPS
-0.30
Operating cash flow
$-10.46M
Free cash flow
$-13.91M
Fetching…
Sources
Revenue
$52.41M
Net income
$-10.66M
Diluted EPS
-0.46
Operating cash flow
$-4.16M
Free cash flow
$-8.38M
Fetching…
Sources
Revenue
$52.67M
Net income
$-16.07M
Diluted EPS
-0.70
Operating cash flow
$-3.99M
Free cash flow
$-4.25M
Fetching…
Sources
Is it cheap or expensive?
Fair value — vs current price $30.87
We couldn't calculate a fair value right now.
Is it drowning in debt?
Distressed
Net debt $66.6M. Interest coverage -12.0x.
Net debt
$66.62M
Interest coverage
-11.96x
OrthoPediatrics Corp.'s profit covers its interest bill about 0.0 times over. which is weaker than most peers shown here and 3 peers sit below 1x, which is the danger zone where profit does not fully cover the interest bill.
Distressed
Worse cushion
Baseline
Better cushion
KIDS
BASELINE
OrthoPediatrics Corp.
Total debt $110.85M Interest coverage -11.96x This is the baseline the peer rows are being compared against.
Total debt $261.90M Interest coverage -4.72x Neither company has much profit cushion over interest right now.
Total debt $73.05M Interest coverage -10.18x Neither company has much profit cushion over interest right now.
Total debt $2.00B Interest coverage 0.21x This peer still has a real interest-payment cushion, while KIDS does not.
Total debt $815.87M Interest coverage 3.30x This peer still has a real interest-payment cushion, while KIDS does not.
What you should know
The case for and against KIDS
1 Reward
1 Risk
Rewards
-
Revenue grew 11.8% last year.
Risks
-
Return on equity was -9.8% last year — the company lost money on shareholders' equity.
The numbers
All the key metrics, grouped by purpose
Tap any ? icon to learn what it means.
Valuation
How expensive the stock looks
P/E (TTM)
—
Forward P/E
-40.94x
P/B
2.38x
P/S
3.05x
EV/EBITDA
772.94x
PEG ratio
—
Profitability
How much profit each dollar creates
Gross margin
73.8%
Operating margin
-5.0%
Net margin
-12.8%
ROE
-9.8%
ROA
-2.7%
Health
Liquidity and balance-sheet strength
Debt / equity
0.33x
Current ratio
4.55x
Quick ratio
1.86x
Total debt
$110.85M
Total cash
$44.23M
Growth
How the business has been compounding
Revenue TTM
$264.14M
Revenue 5Y CAGR
24.6%
EPS TTM
-1.42
EPS 5Y CAGR
—
Cash flow
How much cash the business throws off
Operating CF TTM
$12.49M
Free CF TTM
$-15.96M
FCF margin
-6.0%
Dividend
Shareholder payout
Yield
0.0%
Payout ratio
0.0%
Last ex-div date
—